2-bromo-7-(bromomethyl)-1,8-naphthyridine, 95.0%, 500mg

1-(Chloromethyl)-4-(octyloxy)benzene, 98%, 5g

trans-Ethyl (1R,4R)-4-(cyclopropylamino)cyclohexane-1-carboxylate, 95%, 250mg

Tetrabutyl Orthosilicate>98.0%(GC)25mL

2,3,5-Trifluorobenzoic acid, 98.0%, 10g

2-Amino-2-(tetrahydro-2H-pyran-4-yl)acetic acid hydrochloride, 95.0%, 1g

ETHYL 2-(PIPERAZIN-1-YL)PYRIMIDINE-5-CARBOXYLATE HCL, 95%, 10g

Ethyl 3,4,5-trihydroxybenzoate, 97.0%, 5g

Ethane-1,2-diylbis(triphenylphosphonium) bromide, 98%, 1g

2-(4-Cyclopropylmethanesulfonylphenyl)acetic acid, 98%, 100mg

Di(piperidin-1-yl)methanethione, 97.0%, 100mg

3,3'-Diaminodifenilsulfona, mínimo 99 %, para síntesis, 250 g, envase de plástico.

2-(9,9-Dimethyl-9H-fluoren-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 99%, 250mg